Nov. 09, 2013

Center for Clinical Trials Education

We are pleased to let you know about another lupus clinical trial currently enrolling volunteers.  The study, conducted by the biopharmaceutical company Medimmune, will evaluate the efficacy and safety of Medimmune’s compound MEDI-546 compared to placebo, in patients with chronic, moderate-to-severe active systemic lupus.

Cities where there are trial sites include:
•             Birmingham, AL
•             Chicago, IL
•             Columbus, OH
•             Edmond, OK
•             Florida (Ocala, Orlando, Palm Harbor, Miami)
•             Georgia (Atlanta, Decatur and Stockbridge)
•             Idaho Falls, ID
•             Indianapolis, IN
•             La Cruces, NM
•             Memphis, TN
•             New York (New York City and Lake Success)
•             North Carolina (Charlotte and Raleigh)
•             Southern California
•             Spokane, WA

For additional information, visit